Yusuke Kanemasa

464 total citations
30 papers, 291 citations indexed

About

Yusuke Kanemasa is a scholar working on Oncology, Pathology and Forensic Medicine and Neurology. According to data from OpenAlex, Yusuke Kanemasa has authored 30 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 14 papers in Pathology and Forensic Medicine and 7 papers in Neurology. Recurrent topics in Yusuke Kanemasa's work include Lymphoma Diagnosis and Treatment (13 papers), CNS Lymphoma Diagnosis and Treatment (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Yusuke Kanemasa is often cited by papers focused on Lymphoma Diagnosis and Treatment (13 papers), CNS Lymphoma Diagnosis and Treatment (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Yusuke Kanemasa collaborates with scholars based in Japan. Yusuke Kanemasa's co-authors include Tatsu Shimoyama, Yasushi Omuro, Tsunekazu Hishima, Takeshi Sawada, Yoshiharu Maeda, Miho Tamura, Shohei Nakamura, Kazuaki Fukushima, Akifumi Imamura and Masaru Tanaka and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

Yusuke Kanemasa

26 papers receiving 287 citations

Peers

Yusuke Kanemasa
Yusuke Kanemasa
Citations per year, relative to Yusuke Kanemasa Yusuke Kanemasa (= 1×) peers Akie Hirata

Countries citing papers authored by Yusuke Kanemasa

Since Specialization
Citations

This map shows the geographic impact of Yusuke Kanemasa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yusuke Kanemasa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yusuke Kanemasa more than expected).

Fields of papers citing papers by Yusuke Kanemasa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yusuke Kanemasa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yusuke Kanemasa. The network helps show where Yusuke Kanemasa may publish in the future.

Co-authorship network of co-authors of Yusuke Kanemasa

This figure shows the co-authorship network connecting the top 25 collaborators of Yusuke Kanemasa. A scholar is included among the top collaborators of Yusuke Kanemasa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yusuke Kanemasa. Yusuke Kanemasa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamaguchi, Tatsuro, Masachika Ikegami, Tomoyuki Aruga, et al.. (2024). Genomic landscape of comprehensive genomic profiling in patients with malignant solid tumors in Japan. International Journal of Clinical Oncology. 29(10). 1417–1431. 5 indexed citations
2.
Kanemasa, Yusuke, Yasushi Yagi, Kensei Taguchi, et al.. (2024). Radiation Therapy as a Bridging Strategy in CAR-T Cell Therapy and the Impact of Tumor Control Status at CAR-T Cell Infusion. International Journal of Radiation Oncology*Biology*Physics. 120(2). S207–S207.
3.
Kanemasa, Yusuke, et al.. (2023). Hemoglobin‐platelet index as a prognostic factor in patients with peripheral T‐cell lymphoma. SHILAP Revista de lepidopterología. 4(3). 656–666.
4.
Kanemasa, Yusuke, et al.. (2023). Utility of the frailty score for predicting prognosis and individualizing treatment intensity in elderly patients with diffuse large B cell lymphoma. Annals of Hematology. 102(6). 1485–1500. 3 indexed citations
5.
Ikegami, Masachika, Yusuke Kanemasa, Makiko Yomota, et al.. (2022). Selection bias due to delayed comprehensive genomic profiling in Japan. Cancer Science. 114(3). 1015–1025. 11 indexed citations
6.
Kanemasa, Yusuke, et al.. (2022). Synchronous multiple primary tumors in patients with malignant lymphoma: a retrospective study. BMC Cancer. 22(1). 640–640. 2 indexed citations
7.
Shimoyama, Tatsu, Fumiaki Koizumi, Takeshi Sawada, et al.. (2022). Transcriptomic profiling of single circulating tumor cells provides insight into human metastatic gastric cancer. Communications Biology. 5(1). 20–20. 35 indexed citations
8.
Nakamura, Shohei, Yusuke Kanemasa, Masaru Tanaka, et al.. (2020). Characteristics and outcomes of coronavirus disease 2019 (COVID-19) patients with cancer: a single-center retrospective observational study in Tokyo, Japan. International Journal of Clinical Oncology. 26(3). 485–493. 30 indexed citations
9.
Kanemasa, Yusuke, et al.. (2020). Clinical impact of controlling nutritional status score on the prognosis of patients with diffuse large B‐cell lymphoma. Hematological Oncology. 38(3). 309–317. 27 indexed citations
10.
Kanemasa, Yusuke, et al.. (2020). [Clinical Efficacy of mFOLFOX6 for Advanced Gastric Cancer].. PubMed. 47(1). 49–53. 1 indexed citations
12.
Kanemasa, Yusuke, et al.. (2019). Multimodal Treatment of Extragonadal Choriocarcinoma with Multiple Brain and Lung Metastases: A Case Report. Case Reports in Oncology. 12(3). 928–934. 3 indexed citations
13.
Kanemasa, Yusuke, et al.. (2018). Geriatric nutritional risk index as a prognostic factor in patients with diffuse large B cell lymphoma. Annals of Hematology. 97(6). 999–1007. 52 indexed citations
14.
Kaito, Satoshi, Yusuke Kanemasa, Tatsu Shimoyama, et al.. (2017). A new prognostic score comprising lactate dehydrogenase, albumin and neutrophil to lymphocyte ratio to predict sensitivity to first-line chemotherapy in patients with peripheral T-cell lymphomas. International Journal of Hematology. 107(4). 451–459. 8 indexed citations
15.
Kanemasa, Yusuke, Tatsu Shimoyama, Miho Tamura, et al.. (2017). Analysis of prognostic value of complete response by PET–CT and further stratification by clinical and biological markers in DLBCL patients. Medical Oncology. 34(2). 29–29. 6 indexed citations
16.
Kanemasa, Yusuke, Tatsu Shimoyama, Miho Tamura, et al.. (2017). Analysis of the prognostic value of BMI and the difference in its impact according to age and sex in DLBCL patients. Hematological Oncology. 36(1). 76–83. 6 indexed citations
17.
Kanemasa, Yusuke, Tatsu Shimoyama, Miho Tamura, et al.. (2017). Prognostic significance of CD30 expression in patients with diffuse large B-cell lymphoma. Annals of Oncology. 28. ix82–ix82.
18.
Kanemasa, Yusuke, Tatsu Shimoyama, Miho Tamura, et al.. (2016). Central nervous system relapse in patients with diffuse large B cell lymphoma: analysis of the risk factors and proposal of a new prognostic model. Annals of Hematology. 95(10). 1661–1669. 17 indexed citations
19.
Sawada, Takeshi, Yasushi Omuro, Takeshi Kobayashi, et al.. (2014). Long-term complete remission in a patient with intravascular large B-cell lymphoma with central nervous system involvement. OncoTargets and Therapy. 7. 2133–2133. 5 indexed citations
20.
Kanemasa, Yusuke, Terumi Kamisawa, Taku Tabata, et al.. (2013). Mixed acinar-endocrine carcinoma of the pancreas treated with S-1. Clinical Journal of Gastroenterology. 6(6). 459–464. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026